Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KIAA1551 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IRF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR4D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTFR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928565 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DUSP11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBX15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00441 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBLL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLPP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAIR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESCO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCKDHB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF626 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM229A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on